Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
"We don't need to spend another $140 million to find out how to retain people in care," activist David Barr writes. "We need to invest in the kinds of services people need so that they can use treatment easily and effectively."
Atripla may be just as effective when taken every other day; poor antiretroviral prescription fill rates after hospitalization; U.S. progress against UNAIDS targets; hepatitis C transmission clustering in France.
Although the move means that more Britons might be able to access free PrEP, this study is also controversial for being seen as a way to delay full government approval.
A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.
PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.
More Than 30 Years Later, the UK Government Opens Inquiry Into Blood Contaminated With HIV and Hepatitis C
On Sept. 24, the first widespread inquiry into how thousands of people in the United Kingdom received contaminated blood in the 1970s and 1980s began with a preliminary hearing and a commemoration event dedicated to the victims.
Young people who inject drugs represent a significant portion of new HIV cases around the world, especially in lower-income countries in Eastern Europe, Central Asia, and Southeast Asia, attendees at an AIDS 2018 workshop were told.
Results from the PARTNER2 study, presented by Alison Rodger at AIDS 2018, yielded an equivalent level of confidence for gay men as it had for heterosexual couples in the original PARTNER study several years ago.
A conversation with International AIDS Society president Linda-Gail Bekker about a new report on what the future response to HIV should be, released at the the 22nd International AIDS Conference.